Ars TechnicaCenter·
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Markers released top-line results today after previously reporting the trial succeeded.
Read at Ars Technica →
Technology · 1 sources covering this
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Markers released top-line results today after previously reporting the trial succeeded.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/21d151adc45c2d09db957524325a6ecce1928fa9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%"></iframe>